Addressing the world’s most pressing healthcare challenges
Addressing the world’s most pressing healthcare challenges
Johnson & Johnson MedTech is developing smarter, less invasive, more personalized treatments to tackle the most pervasive and complex diseases for people around the world.
New Data at TCT 2024 Expands on Recently Published New England Journal of Medicine Randomized Controlled Trial Demonstrating a Survival Benefit from Impella® Heart Pumps
New Data at TCT 2024 Expands on Recently Published New England Journal of Medicine Randomized Controlled Trial Demonstrating a Survival Benefit from Impella® Heart Pumps